AESKU  is  actively  committed  to  interdisciplinary  communication and knowledge transfer in the field of autoimmune diseases. AESKU cooperates closely with renowned scientific institutions and scientists on the one hand, and, on the other hand, it has a lively exchange of information with industry to create new opportunities that improve therapy of autoimmune diseases substantially.

Its  unique  corporate  structure  unites  research  on  development, therapy and diagnosis of autoimmune diseases under one roof.

AESKU.SCIENCE is an expression of this commitment. Our magazine intends  to  be  the  basis  for  interdisciplinary  exchange  between the various specialist areas, and between treating physicians and laboratories. AESKU.SCIENCE quite consciously looks at current knowledge  from  a  practical  stance,  so  as  to  bring  research  and daily practice closer together.


aesku science 1


Release Date:

1. November 2004

Main Topics:

  • 100 Years in Autoimmunity
  • A focus on autoimmunity and autoimmune diseases
  • Therapeutic antibodies for SLE
  • German-Israeli research activities on the anti-phospholipid syndrome
  • AESKU autoimmune workshop: a summary
  • Automation in autoimmune diagnostics


aesku science 2


Release Date:

2. October 2005

Main Topics:

  • Celiac disease - is it just the tip of the iceberg?
  • New strategies for early diagnosis
  • Celiac disease: pathogenesis, diagnosis and therapy
  • Screening - a future trend: useful and economic?
  • Rapid test for autoimmune diagnostics
  • 5 years of AESKU


aesku science 3


Release Date:

3. November 2006

Main Topics:

  • Sjögren-Syndrome: New opportunities for early diagnosis
  • Lab automation: opportunity or threat?
  • AESKU.KIPP INSTITUTE: First Research Projects on the Starting Line
  • Challenge Lyme Disease
  • AESKU.AWARD 2006


aesku science 4


Release Date:

6. April 2016

Main Topics:

  • Rheumatic diseases: New opportunities in diagnosis
  • CD74 antibodies a biomarker of axial spondyloarthritis
  • The gut-joint axis and autoimmunity
  • MMP-3: A new prognostic and activity marker for the therapy management of Rheumatoid Arthritis
  • 1st AESKU Latin America workshop
  • 10th anniversary of AESKU.KIPP Institute